Literature DB >> 9061367

Selectin inhibition: synthesis and evaluation of novel sialylated, sulfated and fucosylated oligosaccharides, including the major capping group of GlyCAM-1.

A Koenig1, R Jain, R Vig, K E Norgard-Sumnicht, K L Matta, A Varki.   

Abstract

Selectins interact with glycoconjugate ligands in important normal and pathological situations. While high affinity recognition of natural ligands is associated with alpha 1-3(4)fucosylated, alpha 2-3sialylated (and/or sulfated) lactosamine sequences, small oligosaccharides that potently inhibit the selectins have not been found. One possibility suggested by other investigators is that high affinity may require unusual sequences not yet tested, for example, the "major capping group" (6'-sulfo-sialyl Le(x)) of the L-selectin ligand GlyCAM-1. To explore this possibility, we synthesized a spectrum of novel synthetic and semisynthetic oligosaccharides related to those on natural ligands. In studying these molecules, we noted that binding of recombinant soluble selectins to immobilized sialyl Le(a) or 3'-sulfo-Le(x) is markedly inhibited by concentrations of chloride above the physiological range. This indicates the ionic nature of the interactions, and shows that buffers typically used in screening assays for inhibitors are not optimal. Using parameters that more closely approximate physiological conditions, we confirmed that alpha 2-3-linked sialic acids, and alpha 1-3(4)fucosylation are important for recognition. Similar results obtained with both types of immobilized targets for the three selectins indicated that the binding sites for sialic acid and sulfate are very close, or identical. While O-sulfate esters mostly improved L- and P-selectin recognition, effects depended upon their position and number. Furthermore, sulfation can also impart some "negative" specificity: the major capping group does not interact with E-selectin. The branched Core 2 sequence seemed to enhance L- and P-selectin binding, however, the best inhibitors still appeared to be sialyl Le(a) and 3'-sulfo-Le(x), with the aglycone group of the latter affecting binding. Of particular note, the "major capping group" of GlyCAM-1 was not an unusually potent nor highly selective inhibitor of L-selectin, even when studying the interaction of L-selectin with native GlyCAM-1 itself.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9061367     DOI: 10.1093/glycob/7.1.79

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  16 in total

1.  Endothelial ligands for L-selectin: from lymphocyte recirculation to allograft rejection.

Authors:  S D Rosen
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

2.  Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium.

Authors:  Y J Kim; L Borsig; H L Han; N M Varki; A Varki
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

3.  Human L-selectin preferentially binds synthetic glycosulfopeptides modeled after endoglycan and containing tyrosine sulfate residues and sialyl Lewis x in core 2 O-glycans.

Authors:  Anne Leppänen; Ville Parviainen; Elina Ahola-Iivarinen; Nisse Kalkkinen; Richard D Cummings
Journal:  Glycobiology       Date:  2010-05-27       Impact factor: 4.313

4.  Binding of synthetic sulfated ligands by human splenic galectin 1, a beta-galactoside-binding lectin.

Authors:  H J Allen; H Ahmed; K L Matta
Journal:  Glycoconj J       Date:  1998-07       Impact factor: 2.916

5.  Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents.

Authors:  A Koenig; K Norgard-Sumnicht; R Linhardt; A Varki
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

Review 6.  Substrate and donor specificity of glycosyl transferases.

Authors:  B Ernst; R Oehrlein
Journal:  Glycoconj J       Date:  1999-02       Impact factor: 2.916

7.  A new method for assaying adhesion of cancer cells to the greater omentum and its application for evaluating anti-adhesion activities of chemically synthesized oligosaccharides.

Authors:  A Okamura; S Yazawa; T Nishimura; S Tanaka; I Takai; S Kudo; T Asao; H Kuwano; K L Matta; S Akamatsu; N Kochibe
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

8.  KSGal6ST generates galactose-6-O-sulfate in high endothelial venules but does not contribute to L-selectin-dependent lymphocyte homing.

Authors:  Michael L Patnode; Shin-Yi Yu; Chu-Wen Cheng; Ming-Yi Ho; Lotten Tegesjö; Keiichiro Sakuma; Kenji Uchimura; Kay-Hooi Khoo; Reiji Kannagi; Steven D Rosen
Journal:  Glycobiology       Date:  2012-12-18       Impact factor: 4.313

9.  Glycoforms of human endothelial CD34 that bind L-selectin carry sulfated sialyl Lewis x capped O- and N-glycans.

Authors:  Gerard Hernandez Mir; Jari Helin; Kari-Pekka Skarp; Richard D Cummings; Antti Mäkitie; Risto Renkonen; Anne Leppänen
Journal:  Blood       Date:  2009-04-09       Impact factor: 22.113

Review 10.  Targeting selectins and selectin ligands in inflammation and cancer.

Authors:  Steven R Barthel; Jacyln D Gavino; Leyla Descheny; Charles J Dimitroff
Journal:  Expert Opin Ther Targets       Date:  2007-11       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.